NASDAQ · ADUS
Healthcare · Medical - Care Facilities
$117.95
Down-$0.08 (-0.07%)
Updated Oct 22, 2026, 4:03 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ADUS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 21, 2026
ADUS closed at $117.95 after 21 trading sessions, up 2.63% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | $118.02 | $118.81 | $116.255 | $117.95 | 163.6K |
| Oct 20, 2026 | $116.09 | $118.18 | $116.09 | $118.03 | 138.92K |
| Oct 19, 2026 | $115.98 | $116.85 | $114.71 | $115.16 | 130.41K |
| Oct 16, 2026 | $116.91 | $117.48 | $115.735 | $115.98 | 136.89K |
| Oct 15, 2026 | $117.63 | $118.38 | $116.20 | $116.49 | 172.42K |
| Oct 14, 2026 | $114.34 | $117.10 | $114.17 | $116.62 | 249.67K |
| Oct 13, 2026 | $116.45 | $116.50 | $114.41 | $114.53 | 145.6K |
| Oct 12, 2026 | $115.31 | $117.32 | $114.5325 | $115.475 | 197.86K |
| Oct 9, 2026 | $113.84 | $115.10 | $113.84 | $114.33 | 172.78K |
| Oct 8, 2026 | $113.43 | $115.85 | $112.72 | $114.26 | 146.58K |
| Oct 7, 2026 | $113.16 | $117.313 | $112.905 | $113.27 | 229.45K |
| Oct 6, 2026 | $114.00 | $114.66 | $112.24 | $113.16 | 125.55K |
| Oct 5, 2026 | $111.49 | $113.80 | $110.235 | $112.98 | 218.29K |
| Oct 2, 2026 | $112.37 | $113.075 | $111.135 | $111.27 | 207.75K |
| Oct 1, 2026 | $110.86 | $112.76 | $109.88 | $111.70 | 207.26K |
| Sep 30, 2026 | $113.42 | $113.42 | $110.375 | $110.54 | 330.87K |
| Sep 29, 2026 | $111.50 | $113.24 | $110.47 | $112.96 | 200.48K |
| Sep 28, 2026 | $113.68 | $115.03 | $111.86 | $111.91 | 205.41K |
| Sep 25, 2026 | $114.38 | $114.645 | $112.21 | $113.19 | 216.54K |
| Sep 24, 2026 | $115.84 | $115.93 | $113.57 | $114.05 | 156.53K |
| Sep 23, 2026 | $114.30 | $115.78 | $113.345 | $114.93 | 209.17K |
The latest Smart Investors Daily articles mentioning ADUS.
Company
Market Activity
Research & News
ADUS research
Company profile and research snapshot.
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | B of A Securities | Neutral | — |
| Aug 5, 2026 | RBC Capital | Outperform | — |
| Jul 9, 2026 | Barclays | Underweight | — |
| May 18, 2026 | Citizens | Market Outperform | — |
| May 15, 2026 | Barclays | Underweight | — |
Generated Oct 21, 2026, 9:01 PM
Addus HomeCare Corporation (ADUS) is essentially flat, down just $0.08 (0.07%) in today's trading, as the home care sector remains in focus amid broader healthcare discussions. With minimal direct ADUS-specific news driving the market today, the stock appears to be consolidating while investors monitor sector trends and the company's operational performance.
Bottom line: ADUS is essentially flat today with no major catalysts driving meaningful price movement, reflecting a consolidation period in the stock. Investors should focus on the company's execution on operational metrics and profitability rather than daily volatility, while monitoring sector dynamics and healthcare policy developments that could impact reimbursement rates and labor costs.
Yahoo · Oct 19, 2026
The June closing of the Eucalyptus acquisition transformed Hims & Hers Health (HIMS) into what the company now calls a global consumer health platform. Bears may be overlooking this shift. Investors probably still view the firm as a U.S. telehealth company. The company is losing money, and the stock lost 55.3% in twelve months while the S&P 500 gained 16.2%. So, how big is Hims & Hers outside the U.S.
Yahoo · Oct 13, 2026
FRISCO, Texas, October 13, 2026--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026, after the market close.
Yahoo · Oct 12, 2026
Investors holding Hims & Hers Health (HIMS) face a stark contradiction. The stock has lost 52% in twelve months, while the S&P 500 returned 17.0%. Following that decline, shares now trade at 2.8 times sales, against 3.1 for the index. Yet the company grew sales nearly 40% in fiscal Q2 2026. So where is that growth coming from.
Yahoo · Sep 30, 2026
BrightSpring Health Services is expanding AI and automation across its operations, with early margin gains and more benefits expected later in 2026 and 2027.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ADUS.
